Trials / Completed
CompletedNCT01633346
Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients
Regulation of the Immune System in Response to the Treatment With Tocilizumab in RA Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to know the level of expression and activation state of different transcription factors of the STAT family (STAT1, STAT3, STAT5A, STAT5B, STAT6) in the hematopoietic cells from tocilizumab treated patients.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2016-07-01
- Completion
- 2016-11-01
- First posted
- 2012-07-04
- Last updated
- 2016-11-11
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01633346. Inclusion in this directory is not an endorsement.